New tool could be effective in assessing dementia risk
20 April, 2023Scientists hope the new tool could be used to make it easier for GPs and patients to get information on dementia risk factors.
NARI and Dementia Australia team up to bolster research, advocacy
24 March, 2023The National Ageing Research Institute (NARI) and Dementia Australia have signed a memorandum of understanding (MoU) to jointly pursue research goals.
Dementia test adapted for the hearing impaired
09 March, 2023UQ researchers have adapted a test that screens patients for dementia and Alzheimer's disease to make it suitable for people with hearing loss.
New GP Advice Service as dementia's impact grows
03 March, 2023Dementia Support Australia (DSA) has called for more support and understanding as the number of lives impacted by dementia grows.
Impact of dementia overtakes heart disease for over 65s
24 February, 2023Dementia has overtaken coronary heart disease as the leading cause of disease burden among Australians aged 65 and over.
Workshop on how culture influences dementia
10 February, 2023The online workshop by the National Ageing Research Institute will be held on 15 February from 9:30 am to 12 noon.
Apathy: a possible risk factor for dementia progression
03 February, 2023Apathy increases in patients with mild cognitive impairment and is associated with worse clinical outcomes according to a new study.
Staying at Home initiative supports people with dementia, carers
02 February, 2023Dementia Support Australia's initiative provides strategies for maintaining quality of life that enable people living with dementia and their carers to stay together at home for as long as possible.
Treating hearing loss may lower dementia risk: study
18 January, 2023A new study suggests older adults with severe hearing loss are more likely to have dementia, whilst the likelihood decreases in those who use hearing aids.
US approves new Alzheimer's drug
13 January, 2023A new disease-modifying drug, lecanemab, for people in the early stages of Alzheimer’s disease, has been approved by the US FDA.
Alzheimer's and Parkinson's risk reduced by nature exposure
23 December, 2022US researchers have discovered a potential link between exposure to some types of natural environments and a lower risk of developing Alzheimer's and Parkinson's.
Alzheimer's research sheds light on medication side effects
15 December, 2022The study provides a molecular explanation of the incidence of Amyloid-Related Imaging Abnormalities (ARIA), side effects known to occur in 41% of patients undergoing treatment.
Study explores the prevalence of dementia in centenarians
07 December, 2022The research project brought together studies of centenarians and near-centenarians to look at global prevalence of dementia in the exceptionally old.
Participants needed to test drug treatment for dementia
04 November, 2022Clinical scientists are seeking participants for a Phase 3 clinical trial to test a drug that could slow the process of cognitive decline.
Evidence-based practice to transform care outcomes
31 October, 2022Professor Yun-Hee Jeon, a registered nurse and an academic has spent more than two decades on psychogeriatrics and gerontology research, with a strong passion and determination to improve health and wellbeing of older people and for improving care outcomes.
